As measles cases surge to record levels in the U.S., Health and Human Services Secretary Robert F. | As measles cases surge ...

The United Kingdom is establishing a new biosecurity center designed to improve research into potentially pandemic-causing ...

Abbott is doubling down on the structural heart space, as it aims to gain ground in valve replacements following the recent ...

BioNTech is losing its chief strategy officer, with Ryan Richardson set to leave the company at the end of September to ...

Intuitive Surgical is showing off the remote capability of its robots, with a transatlantic demonstration hosted by the ...

To secure the antibody, I-Mab is paying $1.8 million upfront to buy Bridge Health, to be followed by noncontingent quarterly ...

Novartis has ended work on ianalumab in a painful skin condition after the monoclonal antibody failed to meet “predefined ...

Sarepta Therapeutics is laying off 500 staffers, or 36% of its workforce, as part of a strategic restructuring aiming to save $400 million annually. | Sarepta Therapeutics has laid off 500 staffers, ...

Otsuka Pharmaceutical is putting down $33 million cash for a Swedish biotech’s IL1RAP antibodies designed to treat autoimmune ...

Patients with a mysterious eye pain disease may be one step closer to seeing the first approved treatment for their condition ...

Momentum in Johnson & Johnson’s cardiovascular business continues while the company looks to regain its footing in the ...

The artificial intelligence-powered spine surgery developer Carlsmed is showing some backbone as it kicks off its IPO, with ...